butylbenzyl phthalate has been researched along with Abnormalities, Drug-Induced in 9 studies
spatozoate: structure in first source
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
Excerpt | Relevance | Reference |
---|---|---|
" While only DEHP treatment reduced maternal weight gain during the entire dosing period by about 15 g, both DEHP and DINP reduced pregnancy weight gain to GD 21 by 24 g and 14 g, respectively." | 1.31 | Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. ( Furr, J; Gray, LE; Ostby, J; Parks, L; Price, M; Veeramachaneni, DN, 2000) |
"n-Butyl benzyl phthalate (BBP) and di-n-butyl phthalate (DBP) were evaluated and compared for their developmental toxic potential." | 1.29 | Comparative developmental toxicity of n-butyl benzyl phthalate and di-n-butyl phthalate in rats. ( Amano, H; Ema, M; Kurosaka, R; Ogawa, Y, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sumner, S | 1 |
Snyder, R | 1 |
Burgess, J | 1 |
Myers, C | 1 |
Tyl, R | 1 |
Sloan, C | 1 |
Fennell, T | 1 |
Wilson, VS | 1 |
Lambright, C | 1 |
Furr, J | 2 |
Ostby, J | 2 |
Wood, C | 1 |
Held, G | 1 |
Gray, LE | 2 |
Ema, M | 5 |
Kurosaka, R | 1 |
Amano, H | 1 |
Ogawa, Y | 1 |
Itami, T | 4 |
Kawasaki, H | 4 |
Price, M | 1 |
Veeramachaneni, DN | 1 |
Parks, L | 1 |
Uriu-Adams, JY | 1 |
Kevin Reece, C | 1 |
Nguyen, LK | 1 |
Horvath, BJ | 1 |
Nair, R | 1 |
Barter, RA | 1 |
Keen, CL | 1 |
9 other studies available for butylbenzyl phthalate and Abnormalities, Drug-Induced
Article | Year |
---|---|
Metabolomics in the assessment of chemical-induced reproductive and developmental outcomes using non-invasive biological fluids: application to the study of butylbenzyl phthalate.
Topics: Abnormalities, Drug-Induced; Animals; Endocrine Disruptors; Female; Fetal Development; Magnetic Reso | 2009 |
Phthalate ester-induced gubernacular lesions are associated with reduced insl3 gene expression in the fetal rat testis.
Topics: Abnormalities, Drug-Induced; Androgen Receptor Antagonists; Animals; Dibutyl Phthalate; Diethylhexyl | 2004 |
Comparative developmental toxicity of n-butyl benzyl phthalate and di-n-butyl phthalate in rats.
Topics: Abnormalities, Drug-Induced; Animals; Dibutyl Phthalate; Embryo Loss; Embryonic and Fetal Developmen | 1995 |
Teratogenic phase specificity of butyl benzyl phthalate in rats.
Topics: Abnormalities, Drug-Induced; Animals; Dose-Response Relationship, Drug; Female; Fetus; Male; Phthali | 1993 |
Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat.
Topics: Abnormalities, Drug-Induced; Androgen Antagonists; Animals; Diethylhexyl Phthalate; Female; Fetus; H | 2000 |
Effect of butyl benzyl phthalate on reproduction and zinc metabolism.
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Calcification, Physiologic; Eating; Female; Metal | 2001 |
Effect of period of exposure on the developmental toxicity of butyl benzyl phthalate in rats.
Topics: Abnormalities, Drug-Induced; Animals; Bone and Bones; Corpus Luteum; Eating; Embryo Implantation; Em | 1992 |
Teratogenic evaluation of butyl benzyl phthalate in rats by gastric intubation.
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Eating; Embryo, Mammalian; Female; Fetal Resorpti | 1992 |
Embryolethality and teratogenicity of butyl benzyl phthalate in rats.
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Diet; Eating; Embryo, Mammalian; Female; Fetus; P | 1992 |